Ligation Devices Market is increasingly emerging as an integral aspect of modern surgical treatments due to the emphasis placed on minimally invasive surgeries, high accuracy in surgery, and effective bleeding management by healthcare systems across the world. Ligation devices help in ligating the blood vessels and tissues in various surgeries such as gastrointestinal surgeries, gynecological surgeries, cardiovascular surgeries, urology surgeries, and abdominal surgeries. The increased aging population, high prevalence of chronic and lifestyle diseases, and increasing use of laparoscopic and robotic-assisted surgeries are fueling the demand for ligation devices.
As per SNS Insider, the size of the Ligation Devices Market is estimated to be USD 1.40 billion in 2024, and it is expected to touch USD 2.31 billion by 2032, with a growth rate of 6.52% during 2025-2032. It is backed up by increased surgery rates, high need for minimally invasive surgeries, advances in surgical technology, and focus on patient safety and tissue control. Increased prevalence of colorectal cancer, diverticulitis, varicose veins, cardiovascular diseases, and other surgical procedures is contributing to its growth.
Gain Actionable Intelligence on Ligation Devices Market – Request a Sample Report
Top 3 Ligation Devices Companies
1. Johnson & Johnson
Johnson & Johnson is one of the leading firms that are working in the market for ligation devices with the help of ETHICON Surgical Devices. Johnson & Johnson offers an extensive array of surgical devices that are utilized for tissue management, vessel control, bleeding control and minimal invasive procedures. Its ligation products find usage in gastrointestinal surgery, gynecology, cardiovascular surgery, and general surgery. Johnson & Johnson keeps on improving its surgical device products through innovation. In June 2025, Johnson & Johnson introduced the ETHICON™ 4000 Stapler that comes with ETHICON™ 3D Reloads and ETHICON™ 3D Stapling Technology and advanced Gripping Surface Technology.
2. Medtronic plc
Medtronic remains a significant player in the global market of ligation devices providing high-tech surgical products for vessel and tissue management. The portfolio of Medtronic includes products that can be used in open, laparoscopic, and minimally invasive surgery where vessel closure and hemostasis play a critical role in ensuring the efficiency of the surgical process and patient safety. Investing in new technologies that help to increase surgical accuracy and efficiency, Medtronic is able to take advantage of its widespread presence in hospitals and ambulatory surgery centers as well as its global distribution network.
3. Teleflex Incorporated
Teleflex has created a solid reputation in the surgical devices industry as it supplies equipment that can be employed in accessing blood vessels, performing surgery, and managing tissue. Products developed by Teleflex are intended to assist healthcare professionals to close vessels under control in various surgical operations. The emphasis placed on minimally invasive technologies and efficiency explains Teleflex’s position in the ligation devices segment. As more healthcare facilities continue to look for small-sized, reliable, and simple ligation devices, Teleflex is likely to profit from their implementation.
What is Driving the Future of the Ligation Devices Market?
Growing acceptance of minimally invasive surgeries represents one of the major factors fueling the growth of the ligation devices market. Such surgeries provide advantages like less invasive nature of procedure, smaller cuts, reduced blood loss, shorter hospital stays, faster healing process, and decreased chance of post-surgery complications as compared to conventional surgery methods. Ligation devices such as clip appliers, ligature loops, band ligators, and vessel sealers are vital tools for hemostasis and tissue management during procedures where the surgeon does not have access to the operating site.
Patient safety and surgical accuracy have become other important considerations. Providers of healthcare services are paying much attention to the need to minimize blood loss, avoid complications, and ensure successful results of the surgery. Current ligation devices ensure precise application and closure of vessels and tissues, thus providing the possibility to conduct procedures with great precision.
Gastrointestinal and Abdominal Surgeries was the largest end-use segment of the global market, holding a 35.22% share in 2024. The widespread use of ligation devices in the process of vessel control, blood management, and manipulation of tissues during the surgeries in the abdomen contributes towards dominance of the segment. Cardiovascular surgeries is expected to be the fastest growing end-use segment with a CAGR of 7.04%, due to rising prevalence of cardiovascular disorders worldwide and requirement of precise management of vessels during surgeries.
The Road Ahead
The Ligation Devices Market is expected to witness future growth due to developments in the field of minimally invasive surgery, robotics-based surgeries, sealing of vessels and disposable surgical accessories. Increased expenditure in healthcare and advancements in hospital infrastructure will open up more avenues for growth, especially in emerging economies.
With the continuing rise in the aging population, increase in the prevalence of chronic diseases, and preference for minimally invasive treatment, there will still be high demand for ligation devices in the future. Competition from non-surgical alternatives like laser treatment, sclerotherapy, among others, can be expected to hinder expansion in certain uses of ligation products. Firms that concentrate on increasing accuracy, decreasing procedure time, infection control, and creating devices that can be used on robotic/laparoscopic systems will have the advantage to benefit from opportunities in the ligation device market worldwide.
